Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/01/2008CN101274962A Antibodies against human IL-12
10/01/2008CN101274928A 3-substituted-4-pyrimidone derivatives
10/01/2008CN101274927A Photochemical reaction preparation for quaternary ring compound and use of the quaternary ring compound
10/01/2008CN101274926A Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
10/01/2008CN101274918A Substitutive five membered heterocyclic compound, preparation and medical use thereof
10/01/2008CN101274911A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
10/01/2008CN101274897A Crystalline polymorphs of desvenlafaxine succinate and their preparations
10/01/2008CN101274090A Compound formulation of tablets for improving sleeping quality, tonifying qi and invigorating liver and producing process thereof
10/01/2008CN101274088A Chinese medicine composition for curing schizophrenic and preparation method thereof
10/01/2008CN101274084A Medicament for curing hypertension, hyperlipemia and complication thereof
10/01/2008CN101274068A Compound formulation of capsules for relieving or neutralizing the effect of alcohol and preparing process
10/01/2008CN101274063A External plaster for curing facial nerve paralysis and method of preparing the same
10/01/2008CN101274062A Medicament for giving up smoking
10/01/2008CN101274060A Loins-strengthening and kidney-invigorating paste
10/01/2008CN101274052A Chinese medicinal composition for curing migraine
10/01/2008CN101274023A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274022A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274021A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274020A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274019A Pharmaceutical combination for preventing birth-defect and improving memory
10/01/2008CN101274013A Prescription medicine for curing senile dementia and preparation
10/01/2008CN101274007A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274006A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274005A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274004A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274003A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101274002A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
10/01/2008CN101273983A Use of neurocyte differentiated from stem cell induced by isobavachin
10/01/2008CN101273982A Medicament for preventing or/and treating depression
10/01/2008CN101273789A Summer-heat clearing beverage and its preparing method
10/01/2008CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
10/01/2008CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/01/2008CN100422209C Sea snail toxin variant polypeptide compound, its preparation process and application thereof
10/01/2008CN100422186C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
10/01/2008CN100422183C Diaza-spiropiperidine derivatives as inhibitors of glycine transporter 1 and glycine transporter 2
10/01/2008CN100422182C Imidazopyridine-derivatives as inducible NO-synthase inhibitors
10/01/2008CN100422181C [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
10/01/2008CN100422180C Amyloid plaque aggregation inhibitors and diagnostic imaging agents
10/01/2008CN100422178C Process for producing imide compound
10/01/2008CN100422171C Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/01/2008CN100422166C Method for preparation of citalopram
10/01/2008CN100422164C Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
10/01/2008CN100422161C Hydroxymorpholinone derivative and medicinal use thereof
10/01/2008CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives
10/01/2008CN100422159C Stable polymorph of bifeprunox mesilate
10/01/2008CN100421680C Extractive of ginkgo tree leaves, prepn. method and application thereof
10/01/2008CN100421677C Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn.
10/01/2008CN100421664C Medication for treating convulsion and falling sickness
10/01/2008CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists
09/2008
09/30/2008US7429664 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
09/30/2008US7429663 7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3β inhibitors
09/30/2008US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists
09/30/2008US7429609 Pyrazole compound and medicinal composition containing the same
09/30/2008US7429607 5-HT2B receptor antagonists
09/30/2008US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor
09/30/2008US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008US7429579 antagonism/inhibition, of the D3 receptor; substance abuse.
09/30/2008US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation
09/30/2008US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use
09/30/2008US7429564 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia
09/30/2008US7429559 Controlled release composition and method of producing the same
09/30/2008US7429488 Method for processing lipoaspirate cells
09/30/2008US7429474 2-O sulfatase compositions and methods of analyzing therewith
09/30/2008US7429459 for identifying compounds that inhibit amyloidal-beta precursor protein processing in cells, comprising contacting a test compound with a GPCR polypeptide, or fragment thereof, and measuring a compound-GPCR property related to the production of amyloidal-beta peptide.
09/30/2008CA2355470C Benzoheterocycles and their use as mek inhibitors
09/30/2008CA2314009C Triazole and imidazole derivatives
09/30/2008CA2313642C Pharmaceutical hydrogel formulations, drug delivery devices and methods
09/28/2008CA2627529A1 Fluorinated derivatives of deferiprone
09/25/2008WO2008116226A2 Magnesium compositions and uses thereof
09/25/2008WO2008116185A2 Substituted pyrimidines as adenosine receptor antagonists
09/25/2008WO2008116171A1 Cyclic receptor-associated protein (rap) peptides
09/25/2008WO2008115920A2 Methods for the preparation and formulation of l-carnitine valproate salts
09/25/2008WO2008115919A2 Methods for the preparation, formulation and use of lithium valproate
09/25/2008WO2008115797A1 Therapeutic compositions and methods
09/25/2008WO2008115593A1 1-[(2'-substituted)-piperazin-1'-yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents
09/25/2008WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
09/25/2008WO2008115140A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases
09/25/2008WO2008115139A1 A composition comprising (r)-spiro[l- azabicyclo[2.2.2]octane-3,2'(3'h) -furo[2,3 -b]pyridine (azd0328) and its use in the treatment of alzheimer's disease, adhd or cognitive dysfunction
09/25/2008WO2008115098A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof
09/25/2008WO2008115088A1 Use of rhodamine 6g in the form of a medicinal agent for treating malignant neoplasms and amiloidoses
09/25/2008WO2008114819A1 Novel adenine compound
09/25/2008WO2008114817A1 Novel adenine compound
09/25/2008WO2008114536A1 Dehydroepiandrosterone production promoter and use thereof
09/25/2008WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds
09/25/2008WO2008113795A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/25/2008WO2008113360A2 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
09/25/2008WO2008113359A2 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
09/25/2008WO2008113358A1 Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine
09/25/2008WO2008113100A1 Method for inducing autophagy
09/25/2008WO2008096359A3 Agents for the treatment of multiple sclerosis and methods of using same
09/25/2008WO2008067399A3 Controlled-release multi-layer formulation of piperazine-piperidine antagonists and agonists of the 5-th1a receptor having enhanced intestinal dissolution
09/25/2008WO2008055249A3 Butyrylcholinesterase inhibitors and their use in the treatment of neurodegenerative diseases
09/25/2008WO2008052088A8 Chromane derivatives, synthesis thereof, and intermediates thereto
09/25/2008WO2008046919A3 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
09/25/2008WO2008011007A3 Selective antagonists of a2a adenosine receptors
09/25/2008US20080234483 Fasudil-Containing Preparation and Method of Improving Stability Thereof
09/25/2008US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product
09/25/2008US20080234383 Novel Compounds, Isomer Thereof, or Pharmaceutically Acceptable Salts Thereof as Vanilloid Receptor Antagonist; and Pharmaceutical Compositions Containing the Same
09/25/2008US20080234382 Methods for the preparation, formulation and use of lithium valproate
1 ... 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 ... 1833